MD HB939 | 2024 | Regular Session

Status

Spectrum: Partisan Bill (Democrat 1-0)
Status: Introduced on February 2 2024 - 25% progression, died in committee
Action: 2024-02-05 - Hearing 2/22 at 1:00 p.m.
Pending: House Health and Government Operations Committee
Text: Latest bill text (Introduced) [PDF]

Summary

Requiring insurers, nonprofit health service plans, and health maintenance organizations to limit the amount a covered individual is required to pay in copayments, coinsurance, and deductibles for a covered prescription epinephrine injector to not more than $60.

Tracking Information

Register now for our free OneVote public service or GAITS Pro trial account and you can begin tracking this and other legislation, all driven by the real-time data of the LegiScan API. Providing tools allowing you to research pending legislation, stay informed with email alerts, content feeds, and share dynamic reports. Use our new PolitiCorps to join with friends and collegaues to monitor & discuss bills through the process.

Monitor Legislation or view this same bill number from multiple sessions or take advantage of our national legislative search.

Title

Health Insurance - Epinephrine Injectors - Limits on Cost Sharing (Epinephrine Cost Reduction Act of 2024)

Sponsors


History

DateChamberAction
2024-02-05HouseHearing 2/22 at 1:00 p.m.
2024-02-02HouseFirst Reading Health and Government Operations

Same As/Similar To

SB989 (Crossfiled) 2024-02-06 - Hearing 3/06 at 1:00 p.m.

Subjects


Code Citations

ChapterArticleSectionCitation TypeStatute Text
Insurance15861(n/a)See Bill Text

Maryland State Sources


Bill Comments

feedback